As of December 31, 2008, inhalers using chlorofluorocarbons to dispense albuterol can no longer be produced, marketed, or sold in the United States, according to the FDA. The reason for the ban is that these substances can damage the Earth's protective ozone layer.
Inhalers with albuterol using chlorofluorocarbons as aerosol propellants help stop wheezing, shortness of breath, and labored breathing caused by asthma, chronic bronchitis, and emphysema. Their use had been exempted from the ban. The agency said, however, that there would be enough supplies of albuterol inhalers using environmentally friendly propellants by the end of 2008.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs